[Antimicrobial resistance: it is a global crisis, "a slow tsunami"].

Igiene e sanita pubblica Pub Date : 2019-11-01
Claudio Capozzi, Massimo Maurici, Augusto Panà
{"title":"[Antimicrobial resistance: it is a global crisis, \"a slow tsunami\"].","authors":"Claudio Capozzi,&nbsp;Massimo Maurici,&nbsp;Augusto Panà","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Antimicrobial resistance (AMR) is the phenomenon whereby a microorganism (bacteria, fungi, viruses, and parasites) is resistant to an antimicrobial, previously effective for the treatment of infections generated by it. Although the emergence of AMR is a natural phenomenon, the lack of implementation of infection prevention and control hygiene measures and the excessive and inappropriate use of antimicrobials are among the causes linked to an accelerated appearance and spread of microorganisms resistant to their action, with a consequent loss of efficacy of the treatments and serious risks for public health. Antimicrobial resistant organisms are found in people, food, animals, plants and the environment and can spread among different ecosystems in a global way without respecting geographical borders. Antimicrobial resistance is therefore a global public health problem that requires a global solution. Without proper control and action, AMR will result in enormous human and economic costs. Currently, according to the most recent data available, it is estimated that the AMR is responsible for around 700 thousand deaths worldwide per year (including 230 thousand deaths from multidrug-resistant tuberculosis) and of the 33 thousand deaths that occur in Europe about 11 thousand concern our country, especially for infections contracted in hospital. In the next 35 years, in the absence of measures, it is assumed that worldwide there will be about 300 million people who died prematurely (10 million deaths per year until 2050) with a loss of 100 thousand billion dollars of economic production; in high-income countries it is estimated that between 2015 and 2050 about 2.4 million people could die in the absence of sustained contrast measures over time. The World Health Organization has stated that AMR represents one of the top ten threats to public health worldwide, as it compromises our ability to treat even minor infections, seriously jeopardizes surgical procedures and other advanced medical interventions such as chemotherapy and transplants and more generally endangers the Sustainable Development Goals (SDGs) related to human health and indirectly also the progress of the SDGs aimed at reducing poverty and inequality. We all have a role to play in the fight against AMR, a coordinated effort to address this threat to our health, to our economies is essential: lives around the world depend on this commitment.</p>","PeriodicalId":73329,"journal":{"name":"Igiene e sanita pubblica","volume":"75 6","pages":"429-450"},"PeriodicalIF":0.0000,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Igiene e sanita pubblica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Antimicrobial resistance (AMR) is the phenomenon whereby a microorganism (bacteria, fungi, viruses, and parasites) is resistant to an antimicrobial, previously effective for the treatment of infections generated by it. Although the emergence of AMR is a natural phenomenon, the lack of implementation of infection prevention and control hygiene measures and the excessive and inappropriate use of antimicrobials are among the causes linked to an accelerated appearance and spread of microorganisms resistant to their action, with a consequent loss of efficacy of the treatments and serious risks for public health. Antimicrobial resistant organisms are found in people, food, animals, plants and the environment and can spread among different ecosystems in a global way without respecting geographical borders. Antimicrobial resistance is therefore a global public health problem that requires a global solution. Without proper control and action, AMR will result in enormous human and economic costs. Currently, according to the most recent data available, it is estimated that the AMR is responsible for around 700 thousand deaths worldwide per year (including 230 thousand deaths from multidrug-resistant tuberculosis) and of the 33 thousand deaths that occur in Europe about 11 thousand concern our country, especially for infections contracted in hospital. In the next 35 years, in the absence of measures, it is assumed that worldwide there will be about 300 million people who died prematurely (10 million deaths per year until 2050) with a loss of 100 thousand billion dollars of economic production; in high-income countries it is estimated that between 2015 and 2050 about 2.4 million people could die in the absence of sustained contrast measures over time. The World Health Organization has stated that AMR represents one of the top ten threats to public health worldwide, as it compromises our ability to treat even minor infections, seriously jeopardizes surgical procedures and other advanced medical interventions such as chemotherapy and transplants and more generally endangers the Sustainable Development Goals (SDGs) related to human health and indirectly also the progress of the SDGs aimed at reducing poverty and inequality. We all have a role to play in the fight against AMR, a coordinated effort to address this threat to our health, to our economies is essential: lives around the world depend on this commitment.

[抗菌素耐药性:这是一场全球危机,一场“缓慢的海啸”]。
抗菌素耐药性(AMR)是指微生物(细菌、真菌、病毒和寄生虫)对一种抗菌素产生耐药性的现象,而这种抗菌素以前对治疗由它引起的感染是有效的。虽然抗菌素耐药性的出现是一种自然现象,但缺乏感染预防和控制卫生措施的实施以及过度和不当使用抗菌素是导致对其作用产生耐药性的微生物加速出现和传播的原因之一,从而导致治疗效果丧失,并对公共卫生构成严重风险。抗微生物药物耐药性生物存在于人、食物、动物、植物和环境中,并可在全球不同生态系统中传播,不受地理边界的限制。因此,抗菌素耐药性是一个需要全球解决的全球公共卫生问题。如果没有适当的控制和行动,抗生素耐药性将造成巨大的人力和经济成本。目前,根据现有的最新数据,估计抗生素耐药性每年在全世界造成约70万人死亡(包括23万人死于耐多药结核病),在欧洲发生的3.3万例死亡中,我国约有1.1万例,特别是在医院感染的病例。在未来35年,如果不采取措施,假定全世界将有大约3亿人过早死亡(到2050年每年死亡1000万人),经济生产损失100万亿美元;据估计,在高收入国家,在2015年至2050年期间,如果没有长期持续的对比措施,可能会有大约240万人死亡。世界卫生组织表示,抗菌素耐药性是全球公共卫生的十大威胁之一,因为它损害了我们治疗甚至轻微感染的能力,严重危害外科手术和化疗和移植等其他先进医疗干预措施,更普遍地危及与人类健康有关的可持续发展目标(sdg),并间接危及旨在减少贫困和不平等的可持续发展目标的进展。我们所有人都可以在抗击抗微生物药物耐药性的斗争中发挥作用,协调努力应对这一对我们的健康和经济构成的威胁至关重要:世界各地的生命都取决于这一承诺。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信